Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 5
2015 3
2016 1
2017 2
2018 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
AID/APOBEC deaminases and cancer.
Rebhandl S, Huemer M, Greil R, Geisberger R. Rebhandl S, et al. Oncoscience. 2015 Apr 28;2(4):320-33. doi: 10.18632/oncoscience.155. eCollection 2015. Oncoscience. 2015. PMID: 26097867 Free PMC article. Review.
APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl S, Huemer M, Gassner FJ, Zaborsky N, Hebenstreit D, Catakovic K, Grössinger EM, Greil R, Geisberger R. Rebhandl S, et al. Leukemia. 2014 Sep;28(9):1929-32. doi: 10.1038/leu.2014.160. Epub 2014 May 20. Leukemia. 2014. PMID: 24840555 Free PMC article. No abstract available.
Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.
Gassner FJ, Schubert M, Rebhandl S, Spandl K, Zaborsky N, Catakovic K, Blaimer S, Hebenstreit D, Greil R, Geisberger R. Gassner FJ, et al. Among authors: rebhandl s. Mol Cancer Res. 2018 Mar;16(3):428-438. doi: 10.1158/1541-7786.MCR-17-0373. Epub 2017 Dec 8. Mol Cancer Res. 2018. PMID: 29222170 Free PMC article.
Targeting proliferation of chronic lymphocytic leukemia (CLL) cells through KCa3.1 blockade.
Grössinger EM, Weiss L, Zierler S, Rebhandl S, Krenn PW, Hinterseer E, Schmölzer J, Asslaber D, Hainzl S, Neureiter D, Egle A, Piñón-Hofbauer J, Hartmann TN, Greil R, Kerschbaum HH. Grössinger EM, et al. Among authors: rebhandl s. Leukemia. 2014 Apr;28(4):954-8. doi: 10.1038/leu.2014.37. Epub 2014 Jan 20. Leukemia. 2014. PMID: 24441290 No abstract available.
Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.
Gassner FJ, Zaborsky N, Neureiter D, Huemer M, Melchardt T, Egle A, Rebhandl S, Catakovic K, Hartmann TN, Greil R, Geisberger R. Gassner FJ, et al. Among authors: rebhandl s. Haematologica. 2014 May;99(5):67-9. doi: 10.3324/haematol.2013.098459. Epub 2014 Feb 21. Haematologica. 2014. PMID: 24561794 Free PMC article. No abstract available.
12 results